Floatz logo

FLUOROURACILUM

Pulmonary Embolism

MemorialCare Health SystemSmall moleculePhase 1Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Pulmonary Embolism cohort.

Asset / SponsorPhaseRating
Apixaban
Medical University of Gdansk
Phase 3BB
Tranexamic Acid
Albert Einstein College of Medicine
Phase 4BB
FONDAPARINUX
Johns Hopkins University
Phase 2BB
HEPARIN
Johns Hopkins University
Phase 4B
CIS-DIAMMINEDICHLOROPLATINUM II
MemorialCare Health System
Phase 1CCC

View all 12 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →